BCR/ABL confers growth factor independence upon a murine myeloid cell line

Romeo A. Mandanas, H. Boswell, Li Lu, David Leibowitz

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

The BCR/ABL oncogene in chronic myelogenous leukemia produces an activated tyrosine kinase fusion protein (p210). Like other tyrosine kinase oncogenes, BCR/ABL can abrogate the interleukin-3 (IL-3) dependence of lymphoid cell lines. To investigate the ability of BCR/ABL to generate growth factor independence in myeloid cells, the IL-3 dependent myeloid cell line NFS/N1.H7 (H7) was transfected with the p210BCR/ABL-contairting plasmid, pGD210. Stable clones A54 and A74 were capable of IL-3 independent growth and tumor formation in syngeneic mice. Relief of growth factor dependence was not mediated by autocrine release of IL-3. The baseline proliferation rate of the BCR/ABL transformed cells was greater than that of the parental H7 cells maximally stimulated by IL-3. Abundant constitutive expression of c-myc, c-jun, and c-fos was observed in the p210BCR/ABL transfectants even in low serum conditions. In contrast, c-myc expression in H7 cells was dependent upon IL-3 stimulation, and neither c-jun nor c-fos was highly expressed following IL-3 stimulation in H7 cells. Thus, BCR/ABL transformation and relief of IL-3 dependence involve not only pathways that can substitute for IL-3 induced growth via tyrosine kinase mediated signals, but also pathways that recruit constitutive c-jun and c-fos expression.

Original languageEnglish
Pages (from-to)796-800
Number of pages5
JournalLeukemia
Volume6
Issue number8
StatePublished - Aug 1992

Fingerprint

Interleukin-3
Myeloid Cells
Intercellular Signaling Peptides and Proteins
Cell Line
Protein-Tyrosine Kinases
Oncogenes
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Growth
Signal Transduction
Plasmids
Clone Cells
Lymphocytes

ASJC Scopus subject areas

  • Hematology
  • Cancer Research

Cite this

Mandanas, R. A., Boswell, H., Lu, L., & Leibowitz, D. (1992). BCR/ABL confers growth factor independence upon a murine myeloid cell line. Leukemia, 6(8), 796-800.

BCR/ABL confers growth factor independence upon a murine myeloid cell line. / Mandanas, Romeo A.; Boswell, H.; Lu, Li; Leibowitz, David.

In: Leukemia, Vol. 6, No. 8, 08.1992, p. 796-800.

Research output: Contribution to journalArticle

Mandanas, RA, Boswell, H, Lu, L & Leibowitz, D 1992, 'BCR/ABL confers growth factor independence upon a murine myeloid cell line', Leukemia, vol. 6, no. 8, pp. 796-800.
Mandanas, Romeo A. ; Boswell, H. ; Lu, Li ; Leibowitz, David. / BCR/ABL confers growth factor independence upon a murine myeloid cell line. In: Leukemia. 1992 ; Vol. 6, No. 8. pp. 796-800.
@article{b60b26c5ed8343a2a6c1cc9099000050,
title = "BCR/ABL confers growth factor independence upon a murine myeloid cell line",
abstract = "The BCR/ABL oncogene in chronic myelogenous leukemia produces an activated tyrosine kinase fusion protein (p210). Like other tyrosine kinase oncogenes, BCR/ABL can abrogate the interleukin-3 (IL-3) dependence of lymphoid cell lines. To investigate the ability of BCR/ABL to generate growth factor independence in myeloid cells, the IL-3 dependent myeloid cell line NFS/N1.H7 (H7) was transfected with the p210BCR/ABL-contairting plasmid, pGD210. Stable clones A54 and A74 were capable of IL-3 independent growth and tumor formation in syngeneic mice. Relief of growth factor dependence was not mediated by autocrine release of IL-3. The baseline proliferation rate of the BCR/ABL transformed cells was greater than that of the parental H7 cells maximally stimulated by IL-3. Abundant constitutive expression of c-myc, c-jun, and c-fos was observed in the p210BCR/ABL transfectants even in low serum conditions. In contrast, c-myc expression in H7 cells was dependent upon IL-3 stimulation, and neither c-jun nor c-fos was highly expressed following IL-3 stimulation in H7 cells. Thus, BCR/ABL transformation and relief of IL-3 dependence involve not only pathways that can substitute for IL-3 induced growth via tyrosine kinase mediated signals, but also pathways that recruit constitutive c-jun and c-fos expression.",
author = "Mandanas, {Romeo A.} and H. Boswell and Li Lu and David Leibowitz",
year = "1992",
month = "8",
language = "English",
volume = "6",
pages = "796--800",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - BCR/ABL confers growth factor independence upon a murine myeloid cell line

AU - Mandanas, Romeo A.

AU - Boswell, H.

AU - Lu, Li

AU - Leibowitz, David

PY - 1992/8

Y1 - 1992/8

N2 - The BCR/ABL oncogene in chronic myelogenous leukemia produces an activated tyrosine kinase fusion protein (p210). Like other tyrosine kinase oncogenes, BCR/ABL can abrogate the interleukin-3 (IL-3) dependence of lymphoid cell lines. To investigate the ability of BCR/ABL to generate growth factor independence in myeloid cells, the IL-3 dependent myeloid cell line NFS/N1.H7 (H7) was transfected with the p210BCR/ABL-contairting plasmid, pGD210. Stable clones A54 and A74 were capable of IL-3 independent growth and tumor formation in syngeneic mice. Relief of growth factor dependence was not mediated by autocrine release of IL-3. The baseline proliferation rate of the BCR/ABL transformed cells was greater than that of the parental H7 cells maximally stimulated by IL-3. Abundant constitutive expression of c-myc, c-jun, and c-fos was observed in the p210BCR/ABL transfectants even in low serum conditions. In contrast, c-myc expression in H7 cells was dependent upon IL-3 stimulation, and neither c-jun nor c-fos was highly expressed following IL-3 stimulation in H7 cells. Thus, BCR/ABL transformation and relief of IL-3 dependence involve not only pathways that can substitute for IL-3 induced growth via tyrosine kinase mediated signals, but also pathways that recruit constitutive c-jun and c-fos expression.

AB - The BCR/ABL oncogene in chronic myelogenous leukemia produces an activated tyrosine kinase fusion protein (p210). Like other tyrosine kinase oncogenes, BCR/ABL can abrogate the interleukin-3 (IL-3) dependence of lymphoid cell lines. To investigate the ability of BCR/ABL to generate growth factor independence in myeloid cells, the IL-3 dependent myeloid cell line NFS/N1.H7 (H7) was transfected with the p210BCR/ABL-contairting plasmid, pGD210. Stable clones A54 and A74 were capable of IL-3 independent growth and tumor formation in syngeneic mice. Relief of growth factor dependence was not mediated by autocrine release of IL-3. The baseline proliferation rate of the BCR/ABL transformed cells was greater than that of the parental H7 cells maximally stimulated by IL-3. Abundant constitutive expression of c-myc, c-jun, and c-fos was observed in the p210BCR/ABL transfectants even in low serum conditions. In contrast, c-myc expression in H7 cells was dependent upon IL-3 stimulation, and neither c-jun nor c-fos was highly expressed following IL-3 stimulation in H7 cells. Thus, BCR/ABL transformation and relief of IL-3 dependence involve not only pathways that can substitute for IL-3 induced growth via tyrosine kinase mediated signals, but also pathways that recruit constitutive c-jun and c-fos expression.

UR - http://www.scopus.com/inward/record.url?scp=0026808782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026808782&partnerID=8YFLogxK

M3 - Article

VL - 6

SP - 796

EP - 800

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 8

ER -